Codrituzumab Recombinant Monoclonal Antibody for SPR, Flow, ELISA, Functional Codrituzumab is under investigation in clinical trial NCT01507168 (A Study of RO5137382 (GC33) in Patients With Advanced or Metastatic Hepatocellular Carcinoma).
Codrituzumab Recombinant Monoclonal Antibody for SPR, Flow, ELISA, Functional Codrituzumab is under investigation in clinical trial NCT01507168 (A Study of RO5137382 (GC33) in Patients With Advanced or Metastatic Hepatocellular Carcinoma).
Read more ...